About TALZENNA® (talazoparib) TALZENNA is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA damage repair. Preclinical studies have demonstrated that TALZENNA blocks ...
The approval makes the PARP inhibitor available earlier in the line of treatment for some patients with metastatic disease.
Prostate cancer upgrading was independently associated with elevated PSA density and perineural invasion in a retrospective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results